Glucose-lowering meds compared for use with metformin in T2DM
Oct 03, 2022
Glargine, liraglutide modestly more effective for target glycated hemoglobin levels; microvascular outcomes do not differ materially
Feds expand Jardiance use to all heart failure patients
By
Alicia Lasek
Feb 25, 2022
Originally approved as a glucose control drug for patients with type 2 diabetes, Jardiance has more recently proven effective in reducing mortality and hospitalization in some heart failure patients.
Clinical briefs for Monday, Nov. 1
By
Alicia Lasek
Nov 01, 2021
Decreased vaccine efficacy tied to uptick in COVID cases, Israeli study finds … Newer glucose reducing drugs not linked to fracture risk in seniors with type 2 diabetes: study … Pitfalls of telehealth...
After decade of progress, diabetes control loses steam as first-line therapies go underused
By
Alicia Lasek
Jun 11, 2021
Reinvigorating the use of first-line therapies such as statins, metformin, ACE inhibitors or ARB is key to getting care and outcomes back on track, investigators say.
Drug that targets Alzheimer’s inflammation approved for trial by FDA
By
Alicia Lasek
Feb 09, 2021
An experimental drug meant to treat the “type 3 diabetes” that some scientists believe triggers Alzheimer’s has been approved for a late-stage clinical trial.
AHA highlights game-changing benefits of newer diabetes drugs
By
Alicia Lasek
Sep 30, 2020
Newer classes of diabetes drugs reliably protect patients from heart and kidney damage associated with type 2 diabetes and chronic kidney disease, an American Heart Association analysis finds. Increased...
Metformin may slow cognitive decline in people with diabetes
By
Alicia Lasek
Sep 25, 2020
Researchers have found new potential for a safe and widely used medication. The discovery could be “life-changing” for patients at risk of dementia, they say.
Type 2 diabetes tied to vascular dementia risk — but not Alzheimer’s
By
Alicia Lasek
Sep 23, 2020
A large new study finds that people with type 2 diabetes have a 36% higher risk for vascular dementia when compared with people who do not have diabetes.
Diabetes drugs reduce organ failure, mortality risk in chronic kidney disease
By
Alicia Lasek
Sep 03, 2020
New studies show evidence that common glucose-lowering drugs significantly lower the rate of kidney decline and death.
One in ten with diabetes die within week of COVID-19 hospitalization: Weight a key factor
By
Alicia Lasek
Jun 01, 2020
Researchers have linked higher BMI in diabetes to adverse COVID-19 outcomes in hospitalized patients.